Sponsored diagnostic testing programs for Familial Platelet Disorder with Associated Myeloid Malignancy (FPD/MM)
Familial Platelet Disorder With Associated Myeloid Malignancy is an inherited condition caused by pathogenic variants in RUNX1, leading to lifelong low platelet counts and platelet dysfunction. Affected individuals face an elevated risk of developing myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), often earlier in life compared to the general population.
1 program found for Familial Platelet Disorder with Associated Myeloid Malignancy (FPD/MM)
Invitae Unlock Immunology offers sponsored access to the Inborn Errors of Immunity and Cytopenias Panel, Invitae’s most comprehensive assay for evaluating inherited immune disorders and cytopenias. The panel includes genes tied to combined immunodeficiencies, immune dysregulation, and bone marrow failure, supporting clearer diagnosis and management. U.S. providers may order for eligible patients.
